
JAMA RCT: high-dose vitamin D reduced disease activity in early multiple sclerosis
Louis shares a JAMA trial in which oral cholecalciferol 100,000 IU every two weeks significantly reduced disease activity in clinically isolated syndrome and early relapsing-remitting MS. He speculates it may help other autoimmune diseases. The topic is not cardiovascular.

